Serial Number | 97087466 |
Word Mark | INTRECATE |
Filing Date | Friday, October 22, 2021 |
Status | 732 - THIRD EXTENSION - GRANTED |
Status Date | Tuesday, September 3, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, March 21, 2023 |
Goods and Services | House mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies; pharmaceutical preparations for human use, namely, diagnostic preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals |
Pseudo Mark | INTRICATE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Monday, November 8, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Intrecate Biotherapeutics, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 022102600 |
Party Name | Intrecate Biotherapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Boston, MA 022102600 |
Event Date | Event Description |
Tuesday, August 2, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, October 26, 2021 | NEW APPLICATION ENTERED |
Monday, November 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, August 1, 2022 | ASSIGNED TO EXAMINER |
Tuesday, August 2, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, August 2, 2022 | NON-FINAL ACTION E-MAILED |
Thursday, February 2, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Thursday, February 2, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, February 2, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, February 10, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, May 16, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Friday, August 18, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, August 18, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, August 18, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, August 18, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Monday, November 6, 2023 | SOU TEAS EXTENSION RECEIVED |
Monday, November 6, 2023 | SOU EXTENSION 1 FILED |
Monday, April 22, 2024 | SOU EXTENSION 2 GRANTED |
Monday, November 6, 2023 | SOU EXTENSION 1 GRANTED |
Wednesday, November 8, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, April 22, 2024 | SOU TEAS EXTENSION RECEIVED |
Monday, April 22, 2024 | SOU EXTENSION 2 FILED |
Tuesday, April 23, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, September 3, 2024 | SOU TEAS EXTENSION RECEIVED |
Tuesday, September 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Tuesday, September 3, 2024 | SOU EXTENSION 3 FILED |
Tuesday, September 3, 2024 | SOU EXTENSION 3 GRANTED |